Rafael J. Rojas, Ph.D. - Publications

2007 Pharmacology University of North Carolina, Chapel Hill, Chapel Hill, NC 

14 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 García E, Buenasmañanas D, Martín C, Rojas R. [Sirolimus associated pneumonitis in a hematopoietic stem cell transplant patient]. Medicina ClíNica. 145: 21-3. PMID 25978917 DOI: 10.1016/J.Medcli.2015.02.025  0.4
2015 Rojas RJ, Edmondson DE, Almos T, Scott R, Massari ME. Reversible and irreversible small molecule inhibitors of monoamine oxidase B (MAO-B) investigated by biophysical techniques. Bioorganic & Medicinal Chemistry. 23: 770-8. PMID 25600407 DOI: 10.1016/J.Bmc.2014.12.063  0.4
2011 Hamel B, Monaghan-Benson E, Rojas RJ, Temple BR, Marston DJ, Burridge K, Sondek J. SmgGDS is a guanine nucleotide exchange factor that specifically activates RhoA and RhoC. The Journal of Biological Chemistry. 286: 12141-8. PMID 21242305 DOI: 10.1074/Jbc.M110.191122  0.4
2010 Torres A, Serrano J, Rojas R, Martín V, Martín C, Tabares S, Molina JR, Capote M, Martínez F, Gómez P, Sánchez-García J. Voriconazole as primary antifungal prophylaxis in patients with neutropenia after hematopoietic stem cell transplantation or chemotherapy for acute myeloid leukemia. European Journal of Haematology. 84: 271-3. PMID 19878274 DOI: 10.1111/J.1600-0609.2009.01367.X  0.4
2009 Evelyn CR, Ferng T, Rojas RJ, Larsen MJ, Sondek J, Neubig RR. High-throughput screening for small-molecule inhibitors of LARG-stimulated RhoA nucleotide binding via a novel fluorescence polarization assay. Journal of Biomolecular Screening. 14: 161-72. PMID 19196702 DOI: 10.1177/1087057108328761  0.4
2008 Kelner MJ, McMorris TC, Rojas RJ, Estes LA, Suthipinijtham P. Synergy of irofulven in combination with other DNA damaging agents: synergistic interaction with altretamine, alkylating, and platinum-derived agents in the MV522 lung tumor model. Cancer Chemotherapy and Pharmacology. 63: 19-26. PMID 18305940 DOI: 10.1007/S00280-008-0703-0  0.4
2008 Kelner MJ, McMorris TC, Rojas RJ, Estes LA, Suthipinijtham P. Synergy of Irofulven in combination with various anti-metabolites, enzyme inhibitors, and miscellaneous agents in MV522 lung carcinoma cells: marked interaction with gemcitabine and 5-fluorouracil. Investigational New Drugs. 26: 407-15. PMID 18227973 DOI: 10.1007/S10637-008-9113-8  0.4
2007 Rojas RJ, Yohe ME, Gershburg S, Kawano T, Kozasa T, Sondek J. Galphaq directly activates p63RhoGEF and Trio via a conserved extension of the Dbl homology-associated pleckstrin homology domain. The Journal of Biological Chemistry. 282: 29201-10. PMID 17606614 DOI: 10.1074/Jbc.M703458200  0.4
2005 Pruitt K, Ulkü AS, Frantz K, Rojas RJ, Muniz-Medina VM, Rangnekar VM, Der CJ, Shields JM. Ras-mediated loss of the pro-apoptotic response protein Par-4 is mediated by DNA hypermethylation through Raf-independent and Raf-dependent signaling cascades in epithelial cells. The Journal of Biological Chemistry. 280: 23363-70. PMID 15831492 DOI: 10.1074/Jbc.M503083200  0.4
2003 Rojas RJ, Kimple RJ, Rossman KL, Siderovski DP, Sondek J. Established and emerging fluorescence-based assays for G-protein function: Ras-superfamily GTPases. Combinatorial Chemistry & High Throughput Screening. 6: 409-18. PMID 12769685 DOI: 10.2174/138620703106298509  0.4
2003 Rossman KL, Cheng L, Mahon GM, Rojas RJ, Snyder JT, Whitehead IP, Sondek J. Multifunctional roles for the PH domain of Dbs in regulating Rho GTPase activation. The Journal of Biological Chemistry. 278: 18393-400. PMID 12637522 DOI: 10.1074/Jbc.M300127200  0.4
2002 Kelner MJ, McMorris TC, Rojas RJ, Trani NA, Velasco TR, Estes LA, Suthipinijtham P. Enhanced antitumor activity of irofulven in combination with antimitotic agents. Investigational New Drugs. 20: 271-9. PMID 12201490 DOI: 10.1023/A:1016201807796  0.4
2002 Kelner MJ, McMorris TC, Rojas RJ, Trani NA, Estes L. Enhanced antitumor activity of irofulven in combination with thiotepa or mitomycin C. Cancer Chemotherapy and Pharmacology. 49: 412-8. PMID 11976836 DOI: 10.1007/S00280-001-0410-6  0.4
2000 Kelner MJ, McMorris TC, Estes LA, Oval MY, Rojas RJ, Lynn JR, Lanham KA, Samson KM. Efficacy of MGI 114 (HMAF) against the MRP+ metastatic MV522 lung carcinoma xenograft. Anti-Cancer Drugs. 11: 217-24. PMID 10831281 DOI: 10.1097/00001813-200003000-00010  0.4
Show low-probability matches.